Trial Profile
A Study of the Efficacy and Tolerability of Once Daily Celebrex (Celecoxib) and Three Times Daily Ibuprofen vs. Placebo in the Treatment of Subjects With Osteoarthritis of the Knee
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Ibuprofen
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Pfizer
- 04 Apr 2017 New trial record